CRL's Quality Score rose 1 point on Tue, Nov 10, to 15. Its average daily range eased to 4.9%, under 5%.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 11% from Nov 5 to Nov 10.
| Free cash flow nearly doubled | $294.9M → $518.5M in 3 years |
| Its score | Up:Up to Excellent for the first time since Apr 2024 |
| Latest filing | 8-K, Nov 4 |
After its last 4 reports it closed +0.9% on average, higher 1 of 4 times.
Excellentfor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. CRL scores 15 today, against a median of 10 over its last 20 recorded sessions.
CRL is #26 of 281 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 26 |
Share count against a year before: CRL -2.9%, ICLR -0.6%, IQV -3.2%.
Expected to report Wed Feb 17, before the open (in 99 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.0B, 2% less than a year ago; a profit of $6.86 a share, from $1.10.
“Revenue was $982.7 million, a decrease of 2.2% from $1,004.9 million in the third quarter of 2025, primarily driven by the impact of the May 2026 divestitures.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Service | $780M | $808M | $808M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 4)
No outlook figures read from this release.
“Guidance increases primarily driven by third-quarter outperformance, led by a better-than-expected performance in the DSA segment and a lower tax rate.”
From its results filing (SEC filing · Nov 4)
Sales grew 6.5% a year over 5 years, fiscal 2020 to 2025.
Its share count fell 0.4% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 4, 2026 | -0.6% | -7.3% | -1.7% |
| Aug 5, 2026 | +14.5% | +11.4% | +20.4% |
| May 7, 2026 | +4.2% | -0.0% | -10.4% |
Sales grew in five of the last seven years, to $4B in 2025. It lost money in 2025 after a profit in 2024.
RSI 55.5, MACD below signal, above both averages. Not scored.
3 insiders sold $3M across 11 filings in the last 6 months. No open-market buys on record. The newest:
2 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: CRL is under 0.1% of SPYI, under 0.1% of IVV, and under 0.1% of SPY, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026 (SPY's as filed by IVV).
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
“We compete in the marketplace based on our therapeutic and scientific expertise in early-stage drug research, quality, reputation, flexibility, responsiveness, pricing, innovation and global capabilities.”
CRL scores 15 today, which Breakaway calls Excellent. It is #26 of 281 in Biotech by Quality Score, with 6 of 14 chart checks firing. Up 11% from Nov 5 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
CRL scores 15 today, which Breakaway calls Excellent (15 to 19). That is #26 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind CRL's 15.
3 insiders sold $3M across 11 filings in the last 6 months. No open-market buys on record. The newest is Nancy C. Andrews, Director, who sold $163K on Aug 18. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.